nicotine has been researched along with osteoprotegerin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katono, T; Maeno, M; Motohashi, M; Sato, S; Shoji, M; Suzuki, N; Tanabe, N; Tanaka, H | 1 |
Kim, EC; Kim, HS; Kim, SJ; Kim, Y; Kim, YS; Lee, HJ; Lee, SK; Pi, SH | 1 |
Azarina, A; Ima-Nirwana, S; Maizatul-Neza, J; Nazrun, AS; Norazlina, M; Norliza, M | 1 |
Bosco, AF; Cirelli, JA; de Almeida, JM; Fernandes, LA; Garcia, VG; Macarini, VC; Martins, TM; Nagata, MJ; Theodoro, LH | 1 |
Duan, DM; Ge, X; Liu, YF; Wang, XJ; Wu, LZ; Zhou, ZF | 1 |
Ercan, G; Inan, S; Mizrak, S; Turan, V; Uysal, A; Yilmaz, C | 1 |
Chen, L; Hu, H; Ma, J; Pan, Z; Shangguan, Y; Wang, H; Zhang, X; Zhao, X | 1 |
7 other study(ies) available for nicotine and osteoprotegerin
Article | Year |
---|---|
Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
Topics: Alkaline Phosphatase; Animals; Cell Line, Tumor; Cell Proliferation; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Gene Expression; Glycoproteins; Humans; Lipopolysaccharides; Macrophage Colony-Stimulating Factor; Mice; Nicotine; Osteoblasts; Osteoclasts; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells.
Topics: Alkaline Phosphatase; Antioxidants; Cell Differentiation; Cell Line; Cell Survival; Down-Regulation; Ferritins; Glutamate-Cysteine Ligase; Glutathione Peroxidase; Glutathione Transferase; Heme Oxygenase-1; Humans; Mitogen-Activated Protein Kinases; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nicotinic Agonists; Osteoblasts; Osteocalcin; Osteoclasts; Osteopontin; Osteoprotegerin; Periodontal Ligament; Phosphatidylinositol 3-Kinases; RANK Ligand; Up-Regulation | 2009 |
Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Male; Nicotine; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Vitamin E | 2010 |
Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats.
Topics: Alveolar Bone Loss; Animals; Bacteria; Combined Modality Therapy; Dental Prophylaxis; Disease Models, Animal; Immunohistochemistry; Immunosuppressive Agents; Male; Mandible; Molar; Nicotine; Osteoprotegerin; Periodontitis; Photochemotherapy; Photosensitizing Agents; Random Allocation; RANK Ligand; Rats; Rats, Wistar | 2011 |
Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β.
Topics: Analysis of Variance; Bungarotoxins; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Humans; Interleukin-1beta; Nicotine; Osteoclasts; Osteoprotegerin; Periodontal Ligament; RANK Ligand; Up-Regulation | 2013 |
Effect of nicotine on RANKL and OPG and bone mineral density.
Topics: Absorptiometry, Photon; Administration, Oral; Animals; Bone Density; Dose-Response Relationship, Drug; Female; Male; Models, Animal; Nicotine; Osteoprotegerin; RANK Ligand; Rats; Rats, Inbred Strains; Risk Factors; Spine | 2014 |
Prenatal nicotine exposure retards osteoclastogenesis and endochondral ossification in fetal long bones in rats.
Topics: Animals; Bone Development; Cells, Cultured; Chondrocytes; Corticosterone; Female; Femur; Gestational Age; Maternal Exposure; Nicotine; Nicotinic Agonists; Osteoclasts; Osteogenesis; Osteoprotegerin; Pregnancy; RANK Ligand; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Nicotinic; Tibia | 2018 |